CorMedix replaces CBIZ CPAs with Ernst & Young as auditor
CorMedix Inc.'s Audit Committee dismissed CBIZ CPAs P.C. as its independent registered public accounting firm on June 25, 2026, and appointed Ernst & Young LLP as its successor for the fiscal year ending December 31, 2026. CBIZ CPAs' audit reports on the Company's 2025 financial statements contained no adverse opinion, disclaimer, or qualification. The Company disclosed one reportable event during CBIZ CPAs' tenure: a material weakness in internal control over financial reporting related to review of significant, non-routine transactions, which was reported in the Company's 2025 Form 10-K filed March 5, 2026.
Key facts
- CBIZ CPAs P.C. dismissed June 25, 2026
- Ernst & Young LLP appointed June 25, 2026
- Material weakness in internal control over financial reporting disclosed in 2025 Form 10-K (March 5, 2026)
- No disagreements with CBIZ CPAs on accounting principles, disclosure, or auditing scope from April 17, 2025 through June 25, 2026
- CBIZ CPAs acquired Marcum LLP's attest business; Marcum was dismissed April 17, 2025
Why it matters
The auditor change occurs under a disclosed material weakness in internal controls, signaling governance concerns that the new auditor will inherit and assess in its 2026 audit.
Share
Derived from 8-K filed 2026-07-01. Not investment advice. View the source filing on SEC.gov →